Market Overview | | | S&P 500 | | +0.58% | | Pre: -0.37% |
| | | Nasdaq | | +0.45% | | Pre: -0.68% |
| | |
|
|
|
Stock & Market News | | - Google & Constellation ink deals: Google (GOOGL) signed deals for 3.6 GW of power from Constellation Energy (CEG), including 890 MW of nuclear capacity. Constellation will invest over $4.3B as AI data centers drive U.S. electricity demand higher. Source: Reuters.
- Google halts Finland data centers: Google (GOOGL) is halting work on two Finnish data centers pending environmental reviews, complicating its $15B AI infrastructure investment plan in Finland. Source: CNBC.
- Uber buys ezCater for $2.3B: Uber (UBER) is buying catering platform ezCater for $2.3B in cash to expand corporate food delivery. EzCater generated over $2.5B in annual gross bookings. Source: Reuters.
- SpaceX seeks $40B: SpaceX (SPCX) is in early talks to raise $40B in debt to buy Nvidia (NVDA) chips for its AI buildout. The financing could include about $10B in bank loans and $30B in investment-grade debt. Source: Bloomberg.
- Microsoft & Nvidia unveil AI laptop: Microsoft (MSFT) and Nvidia (NVDA) are unveiling the Surface Laptop Ultra today, designed to run AI agents locally. High memory costs could limit adoption as Nvidia recently raised its DGX Spark price by 75%. Source: Reuters.
- Mistral unveils flagship model: Mistral unveiled its 1-trillion-parameter Large 4 model, claiming it is the strongest open-weight AI model developed outside of China. It was trained on 4,000 Nvidia (NVDA) Grace Blackwell GPUs. Source: CNBC.
- Anthropic expands startup push: Anthropic is expanding its Claude Startups program, offering eligible companies up to $45,000 in discounts and credits plus other benefits. Source: CNBC.
- Tesla pushes EU for FSD approval: Tesla (TSLA) has secured Dutch backing for EU-wide Full Self-Driving approval after pressing regulators to ease reviews. Safety experts told Reuters that Tesla’s research does not support its claims that FSD prevents deaths. Source: Reuters.
- AI simulates drug trial outcomes: AI firms are using virtual trials to predict drug success before costly human studies. BioinvestGPT correctly forecasted five of six recent outcomes, highlighting the potential to reduce failures and R&D costs across pharma. Source: Reuters.
- EU weighs Chinese hybrid cap: The EU is considering measures to limit Chinese hybrid-vehicle imports after their European market share surged, potentially supporting Volkswagen (ETR:VOW3), Renault (EPA:RNO), and Mercedes-Benz (ETR:MBG). Source: Bloomberg.
- Nestlé targets youth with NBA deal: Nestlé (SWX:NESN) is launching its biggest international sponsorship through an NBA partnership spanning 21 countries, aiming to boost youth engagement and position its cocoa and malt drinks around fitness and nutrition. Source: Reuters.
- WHO limits child obesity drugs: The WHO is recommending behavioral modifications over weight loss drugs for children, with GLP-1s reserved for adolescents when other interventions fail. The guidance could temper pediatric demand for GLP-1s. Source: Reuters.
- U.S. luxury spending weakens: U.S. luxury credit card spending fell 6% YoY in September, marking a third monthly decline. The slowdown could pressure Tapestry (TPR), LVMH (TSX:LVMH), and other luxury brands as they approach earnings season. Source: Reuters.
|
|
|
|
Economic News | |  | | Photo by Andy Li on Unsplash | | - U.S. trade deficit widens: The U.S. trade deficit rose 13.7% to a 17-month high of $105.6B in August as record imports, including AI chips, outpaced exports. Economists warn the widening gap could weigh on Q3 economic growth. Goldman Sachs (GS) cut its Q3 GDP growth estimate to 3.1%. Sources: NY Times / CNBC.
- Treasury yields hit 24-year highs: The 10-year Treasury yield is climbing to 5.35%, its highest since 2002, as investors brace for a $39B auction. Inflation, rising energy prices, and debt concerns are driving a global bond selloff. Source: CNBC.
- Mortgage rates hit 3-year high: The average U.S. 30-year mortgage rate jumped 19 basis points to 7.49%, its highest since 2023, as Treasury yields surged. Mortgage applications fell 4.2%, adding pressure to housing affordability and demand. Source: Reuters.
- Fed minutes may reveal policy split: Fed minutes are expected to show disagreement over further rate hikes after September’s increase to 3.75%–4.00%. Softer inflation and jobs data have shifted markets toward expecting rates to remain unchanged in October. Source: Reuters.
- IMF flags AI boom risks, French deficit: IMF chief Kristalina Georgieva says AI could add up to 0.5 percentage points to annual global growth, but heavy borrowing and stretched valuations could amplify a market shock if earnings disappoint. She also urged France to rein in its deficit as political unrest and high debt push 10-year bond yields higher, warning that borrowing costs could climb further. Sources: CNBC / CNBC.
- RBI raises rates to 5.5%: India’s central bank is raising its benchmark rate by 25 basis points to 5.5%, its first hike since 2023, as inflation accelerates. The RBI also raised its growth forecast to 7.1%, while signaling further tightening is possible. Source: CNBC.
|
|
|
|
World News & Politics | | - Israel marks attack anniversary: Israel is marking three years since the Hamas-led attacks that killed about 1,200 people and resulted in 251 people being taken hostage. Memorials come as violence continues in Gaza despite a ceasefire, with much of the territory in ruins. New reports say Israeli PM Netanyahu and security agencies received warnings before the attack, which Netanyahu denies. Sources: BBC / NPR.
- Ukraine regains Donbas ground: Ukraine has reclaimed territory in the Donbas through a months-long counteroffensive, slowing Russia’s push toward key cities. Russian territorial gains across Ukraine have slowed markedly in 2026 despite continued assaults. Source: NY Times.
- Nobel Prize winners in science: Henri B. Kagan and Kenso Soai have won the 2026 Nobel Prize in chemistry for advances that transformed the development of pharmaceuticals, flavors, scents, and more. Francis Halzen won the Prize in physics for pioneering the IceCube observatory, which has opened a new way to study distant cosmic events. Sources: CNN / Reuters.
- Trump remark draws backlash: President Trump’s suggestion that Iran could “take out” Los Angeles or San Diego drew criticism from California Democrats and some Republicans. The White House said he meant the war prevented Iran from threatening U.S. cities. Source: Reuters.
- CFPB eases financial oversight: The CFPB is taking a lighter approach to financial supervision, sources say, with over half of spring exams receiving expedited reviews and only about 70 companies selected for 2026 exams — roughly half of the usual number. Source: Reuters.
|
|
|
|
Economic Events | | - 7:00 AM: MBA 30-Year Mortgage Rate
- 10:30 AM: EIA Crude Oil & Gasoline Stocks Change
- 2:00 PM: FOMC Minutes
- Friday: Michigan Consumer Sentiment Prelim.
|
| |
|
|
Recent Earnings | | Constellation Brands (STZ) has released its quarterly earnings. Lamb Weston Holdings (LW) has released its quarterly earnings. |
| | View Earnings Calendar |
|
|
Upcoming Earnings | | Levi Strauss & Co. (LEVI) will report today after close. Applied Digital (APLD) will report today after close. PepsiCo (PEP) will report tomorrow before market open. Delta Air Lines (DAL) will report Friday. JPMorgan Chase (JPM) will report Tuesday. Johnson & Johnson (JNJ) will report Tuesday. UnitedHealth Group (UNH) will report Tuesday. The Goldman Sachs Group (GS) will report Tuesday. Wells Fargo & Company (WFC) will report Tuesday. Citigroup (C) will report Tuesday. |
| | View Earnings Calendar |
|
|
This Week's IPOs | | - Estimated Friday, Oct. 9: Retension Pharmaceuticals, Inc. (RTSN), a clinical-stage biopharma firm focused on cardiovascular medicines.
- Estimated Friday, Oct. 9: TRex Bio, Inc. (TRXB), a clinical-stage biopharma company developing medicines for autoimmune and inflammatory diseases.
|
| | View IPO Calendar | |
|
|